After confirming eligibility, participants who qualify for the POLARIS Study are enrolled.
Participants are followed for up to 1.5 years after receiving a single dose of GNTI-122.
Study procedures may include:
Before enrolling, the study team will explain in detail what participants can expect during the study.
All tests and procedures are of no cost to you, and you will be compensated for your time and travel.